未治疗宫颈上皮内瘤变2级主动监测的临床病程:系统综述与荟萃分析
该系统综述与荟萃分析纳入36项研究共3160例组织学确诊的CIN2非妊娠女性,评估保守管理至少3个月后的消退、持续和进展率。24个月时汇总消退率为50%、持续率为32%、进展率为18%;<30岁女性消退率达60%。前瞻性研究中6-24个月随访不依从率约10%。结论认为多数CIN2尤其年轻女性可自发消退,支持主动监测而非立即干预。
要点
- 24个月时CIN2汇总消退率50%、持续率32%、进展率18%。
- <30岁女性24个月消退率60%,持续率23%,进展率11%。
- 前瞻性研究中6-24个月随访不依从率约10%。
核心结论
- 多数CIN2病变尤其年轻女性(<30岁)可自发消退,支持主动监测而非立即干预。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、Embase和CINAHL从1973年1月1日至2016年8月20日。
- 纳入36项研究共3160例组织学确诊CIN2的非妊娠女性,保守管理至少3个月。
- 纳入研究包括7项随机试验、16项前瞻性队列和13项回顾性队列,50%研究为低偏倚风险。
主要发现
- 24个月时汇总消退率为50%(11项研究,819/1470例,95%CI 43%-57%;I2=77%)。
- 24个月时汇总持续率为32%(8项研究,334/1257例,95%CI 23%-42%;I2=82%)。
- 24个月时汇总进展率为18%(9项研究,282/1445例,95%CI 11%-27%;I2=90%)。
- <30岁女性亚组(1069例)24个月消退率60%(4项研究,638/1069例,95%CI 57%-63%;I2=0%)。
- <30岁女性亚组24个月持续率23%(2项研究,226/938例,95%CI 20%-26%;I2=97%),进展率11%(3项研究,163/1033例,95%CI 5%-19%;I2=67%)。
临床怎么用
- 对CIN2尤其年轻女性可考虑主动监测而非立即干预,前提是能依从随访。
局限性
- 各结局汇总分析异质性较高(I2最高达90%),部分亚组研究数量少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To estimate the regression, persistence, and progression of untreated cervical intraepithelial neoplasia grade 2 (CIN2) lesions managed conservatively as well as compliance with follow-up protocols. DESIGN: Systematic review and meta-analysis. DATA SOURCES: Medline, Embase, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) from 1 January 1973 to 20 August 2016. ELIGIBILITY CRITERIA: Studies reporting on outcomes of histologically confirmed CIN2 in non-pregnant women, managed conservatively for three or more months. DATA SYNTHESIS: Two reviewers extracted data and assessed risk of bias. Random effects model was used to calculate pooled proportions for each outcome, and heterogeneity was assessed using I2 statistics. MAIN OUTCOME MEASURES: Rates of regression, persistence, or progression of CIN2 and default rates at different follow-up time points (3, 6, 12, 24, 36, and 60 months). RESULTS: 36 studies that included 3160 women were identified (seven randomised trials, 16 prospective cohorts, and 13 retrospective cohorts; 50% of the studies were at low risk of bias). At 24 months, the pooled rates were 50% (11 studies, 819/1470 women, 95% confidence interval 43% to 57%; I2=77%) for regression, 32% (eight studies, 334/1257 women, 23% to 42%; I2=82%) for persistence, and 18% (nine studies, 282/1445 women, 11% to 27%; I2=90%) for progression. In a subgroup analysis including 1069 women aged less than 30 years, the rates were 60% (four studies, 638/1069 women, 57% to 63%; I2=0%), 23% (two studies, 226/938 women, 20% to 26%; I2=97%), and 11% (three studies, 163/1033 women, 5% to 19%; I2=67%), respectively. The rate of non-compliance (at six to 24 months of follow-up) in prospective studies was around 10%. CONCLUSIONS: Most CIN2 lesions, particularly in young women (<30 years), regress spontaneously. Active surveillance, rather than immediate intervention, is therefore justified, especially among young women who are likely to adhere to monitoring. SYSTEMATIC REVIEW REGISTRATION: PROSPERO 2014: CRD42014014406.
引用
- Tainio K, Athanasiou A, Tikkinen KAO, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ. 2018. PMID: 29487049. doi:10.1136/bmj.k499
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。